Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Journal of Clinical Microbiology|May 31, 2013
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistanceMichael A Pfaller, Shawn A Messer, Leah N Woosley, et al.International Journal of Antimicrobial Agents|August 18, 2014
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infectionsMariana Castanheira, Shawn A Messer, Ronald N Jones, et al.Journal of Clinical Microbiology|October 25, 2013
Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteriaMichael A Pfaller, Shawn A Messer, Daniel J Diekema, et al.The Journal of Antimicrobial Chemotherapy|June 12, 2016
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolatesMichael A Pfaller, Shawn A Messer, Paul R Rhomberg, et al.Diagnostic Microbiology and Infectious Disease|September 16, 2011
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution methodMichael A Pfaller, Mariana Castanheira, Daniel J Diekema, et al.Diagnostic Microbiology and Infectious Disease|April 17, 2014
Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida sppMichael A Pfaller, Mariana Castanheira, Shawn A Messer, et al.The Journal of Antimicrobial Chemotherapy|November 27, 2004
Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Shawn A Messer, Jeffrey T Kirby, Helio S Sader, et al.Journal of Clinical Microbiology|November 1, 2002
Presumptive identification of Candida kefyr on levine formulation of eosin methylene blue agarErik L Munson, Dennis R Troy, Joanne K Weber, et al.American Journal of Obstetrics and Gynecology|September 1, 2009
Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategiesJanet I Andrews, Diedre K Fleener, Shawn A Messer, et al.Diagnostic Microbiology and Infectious Disease|June 24, 2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution methodMichael A Pfaller, Katsura Hata, Ronald N Jones, et al.Pageof 7